{"name": "Sciele Pharma",
 "permalink": "sciele-pharma",
 "crunchbase_url": "http://www.crunchbase.com/company/sciele-pharma",
 "homepage_url": "http://www.scielepharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1992,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "prescription-medication, branded-medication, pharmaceuticals",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Branded Prescription Sales",
 "created_at": "Wed Sep 23 23:32:26 UTC 2009",
 "updated_at": "Wed Sep 23 23:36:18 UTC 2009",
 "overview": "\u003Cp\u003ESciele Pharma, Inc., a Shionogi company, is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women\u0026#8217;s Health and Pediatrics. \u003C/p\u003E\n\n\u003Cp\u003EThe Company\u0026#8217;s Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and type 2 diabetes; its Women\u0026#8217;s Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, and attention deficit/hyperactivity disorder (ADHD).\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       84],
      "assets/images/resized/0006/0643/60643v1-max-150x150.jpg"],
     [[250,
       140],
      "assets/images/resized/0006/0643/60643v1-max-250x250.jpg"],
     [[325,
       182],
      "assets/images/resized/0006/0643/60643v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 29000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://ir.sciele.com/phoenix.zhtml?c=120763\u0026p=irol-newsArticle\u0026ID=1359005\u0026highlight=",
    "source_description": "Sciele Pharma, A Shionogi Company, To Acquire Addrenex Pharmaceuticals, Inc., A U.S. Specialty Pharmaceutical Company",
    "acquired_year": 2009,
    "acquired_month": 11,
    "acquired_day": 16,
    "company":
     {"name": "Addrenex Pharmaceuticals",
      "permalink": "addrenex-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            36],
           "assets/images/resized/0007/4059/74059v1-max-150x150.jpg"],
          [[250,
            61],
           "assets/images/resized/0007/4059/74059v1-max-250x250.jpg"],
          [[288,
            71],
           "assets/images/resized/0007/4059/74059v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "Atlanta",
    "state_code": "GA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ: SCRX"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}